Suppr超能文献

全血中肿瘤坏死因子-α刺激释放与耐多药肺结核患者化疗反应的相关性研究。

Association of antigen-stimulated release of tumor necrosis factor-alpha in whole blood with response to chemotherapy in patients with pulmonary multidrug-resistant tuberculosis.

机构信息

Division of Immunopathology and Cellular Immunology, and of Molecular Microbiology, International Tuberculosis Research Center, Masan, Republic of Korea. syeumkr @ gmail.com

出版信息

Respiration. 2010;80(4):275-84. doi: 10.1159/000283687. Epub 2010 Feb 10.

Abstract

BACKGROUND

We have previously reported that TNF-α levels correlate to total mycobacterial burden in tuberculosis (TB) patients.

OBJECTIVE

To characterize the dynamics of cytokine responses in TB patients during chemotherapy to identify potential surrogate markers for effective treatment.

METHODS

Following induction by culture filtrate proteins in whole blood, production patterns of TNF-α, IL-10, IFN-γ and IL-12 were measured in 23 non-multidrug-resistant (MDR)-TB and 16 MDR-TB patients and in 31 healthy controls. Rates of mycobacterial clearance from the sputum were then measured and compared.

RESULTS

Prior to the initiation of chemotherapy, TNF-α and IL-10 levels were significantly higher in TB patients than in healthy controls while IFN-γ and IL-12 levels were similar. During chemotherapy, the levels of all 4 cytokines increased. We evaluated these responses separately in patients that did and did not clear their sputum culture at 2 and 6 months. At 2 months, decreases in both IFN-γ and IL-12 correlated strongly with a successful early response, while after 6 months of therapy, when half (7/14) of MDR-TB patients were still sputum culture positive, downregulation of TNF-α was uniquely correlated with sputum conversion between the groups.

CONCLUSION

Our findings suggest the possibility that the regulation of TNF-α production in whole blood may be a more specific indicator of sputum conversion at 6 months than IFN-γ, IL-12 or IL-10 in MDR-TB patients.

摘要

背景

我们之前曾报道过 TNF-α 水平与结核病(TB)患者的总分枝杆菌负荷量相关。

目的

描述 TB 患者在化疗期间细胞因子反应的动态变化,以确定潜在的治疗效果替代标志物。

方法

采用全血培养滤液蛋白进行诱导后,我们检测了 23 例非耐多药(MDR)-TB 和 16 例 MDR-TB 患者及 31 例健康对照者的 TNF-α、IL-10、IFN-γ 和 IL-12 的产生模式。然后测量并比较痰液中分枝杆菌清除率。

结果

在开始化疗之前,TB 患者的 TNF-α 和 IL-10 水平明显高于健康对照组,而 IFN-γ 和 IL-12 水平相似。在化疗期间,所有 4 种细胞因子的水平均升高。我们分别评估了在 2 个月和 6 个月时痰液培养转阴和未转阴的患者对这些反应的反应。在 2 个月时,IFN-γ 和 IL-12 的降低与早期成功应答密切相关,而在 6 个月的治疗后,当一半(7/14)的 MDR-TB 患者仍为痰培养阳性时,TNF-α 的下调与组间痰转化的相关性最为独特。

结论

我们的研究结果提示,在 MDR-TB 患者中,与 IFN-γ、IL-12 或 IL-10 相比,全血中 TNF-α 产生的调节可能是 6 个月时痰转化的更特异性标志物。

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验